The market of Northern Ireland

This procedure establishes specific regulations for pharmaceutical products intended for the Northern Ireland market. It aims to ensure that medicines are available and safe while managing the unique regulatory position of Northern Ireland following the UK's exit from the European Union.

This affects pharmaceutical companies and healthcare providers operating in Northern Ireland, ensuring they comply with both EU standards and specific local market requirements.